Epidemiology of Staphylococcus aureus infections in Timor-Leste, January–July 2020
Communicable Diseases Intelligence · 28.04.2026 · 50
DOI: 10.33321/cdi.2026.50.028 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Communicable Diseases Intelligence, online erschienen am 28.04.2026. Verfasst von Virginia de L da Conceição und 9 weiteren Autor:innen. Beteiligte Einrichtung: Menzies School of Health Research, Charles Darwin University, Dili, Timor-Leste; Laboratório da Saúde - Instituto Nacional da Saúde Pública de Timor-…. Hauptthemen laut MEDLINE: Staphylococcal Infections, Staphylococcus aureus. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BackgroundThe nation of Timor-Leste has a significant burden of infectious disease but has historically had limited diagnostic capacity and limited availability of microbiology data on human health. Recent developments in the diagnosis and reporting of key pathogens including Staphylococcus aureus have allowed better understanding of the burden of key infectious diseases and their impact on the population of Timor-Leste. MethodsA prospective observational study was performed on clinical isolates of S. aureus received at Laboratório da Saúde in Dili, Timor-Leste between January 2020 and July 2020. Clinical samples were obtained from patients living in 11 of the 13 municipalities in Timor-Leste. Standard microbiology culture, identification, and antimicrobial susceptibility testing were performed, and clinical and demographic data were collected on laboratory-confirmed S. aureus isolates. ResultsA total of 59 clinical isolates of S. aureus were identified. Most patients in our study were found to have community-acquired S. aureus (75%), whilst the remaining 25% were hospital-associated infections. Of S. aureus isolates, 25% were found to be methicillin-resistant. ConclusionThis is the first description of S. aureus infections in Timor-Leste. The high MRSA rates identified in this study can be used to better inform guidelines for the empirical treatment of S. aureus infection. Continuous investment in detecting clinically important pathogens and understanding their susceptibility profiles is critical for the development of treatment guidelines and antibiotic stewardship activities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Menzies School of Health Research, Charles Darwin University, Dili, Timor-Leste; Laboratório da Saúde - Instituto Nacional da Saúde Pública de Timor-Leste, Dili, Timor-Leste. virginia.conceicao2@menzies.edu.au.
- Menzies School of Health Research, Charles Darwin University, Dili, Timor-Leste; Laboratório da Saúde - Instituto Nacional da Saúde Pública de Timor-Leste, Dili, Timor-Leste.
- Hospital Nacional Guido Valadares (HNGV), Dili, Timor-Leste.
- Menzies School of Health Research, Charles Darwin University, Dili, Timor-Leste.
- Menzies School of Health Research, Charles Darwin University, Dili, Timor-Leste; Infectious Diseases Specialist, The Canberra Hospital, Canberra, Australia.
- Australian e-Health Research Centre CSIRO, Brisbane, Queensland, Australia. teresa.wozniak@csiro.au.
Zitieren
APA
da Conceição, V. L., Sarmento, N. D. C., Matoso, E., Soares, N., Oakley, T., Marr, I., Alves, L., Yan, J., Francis, J., & Wozniak, T. (2026). Epidemiology of Staphylococcus aureus infections in Timor-Leste, January–July 2020. Communicable Diseases Intelligence, 50. https://doi.org/10.33321/cdi.2026.50.028
Vancouver
da Conceição VL, Sarmento NDC, Matoso E, Soares N, Oakley T, Marr I, et al. Epidemiology of Staphylococcus aureus infections in Timor-Leste, January–July 2020. Communicable Diseases Intelligence. 2026;50. doi:10.33321/cdi.2026.50.028
BibTeX
@article{daConceio2026,
author = {da Conceição, Virginia de L and Sarmento, Nevio da C and Matoso, Edson and Soares, Narcisio and Oakley, Tessa and Marr, Ian and Alves, Lucsendar and Yan, Jennifer and Francis, Joshua and Wozniak, Teresa},
title = {Epidemiology of Staphylococcus aureus infections in Timor-Leste, January–July 2020},
journal = {Communicable Diseases Intelligence},
year = {2026},
volume = {50},
doi = {10.33321/cdi.2026.50.028}
}
EUVIMED